ITRM20050169A1 - Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento. - Google Patents
Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento.Info
- Publication number
- ITRM20050169A1 ITRM20050169A1 IT000169A ITRM20050169A ITRM20050169A1 IT RM20050169 A1 ITRM20050169 A1 IT RM20050169A1 IT 000169 A IT000169 A IT 000169A IT RM20050169 A ITRM20050169 A IT RM20050169A IT RM20050169 A1 ITRM20050169 A1 IT RM20050169A1
- Authority
- IT
- Italy
- Prior art keywords
- medicines
- characterization
- genes
- model system
- control aging
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000169A ITRM20050169A1 (it) | 2005-04-07 | 2005-04-07 | Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento. |
| EP05823575A EP1871427A2 (fr) | 2005-04-07 | 2005-12-22 | Utilisation de nothobranchius furzeri en tant que systeme de modele pour la caracterisation de medicaments qui regulent le vieillissement |
| PCT/IT2005/000753 WO2006106544A2 (fr) | 2005-04-07 | 2005-12-22 | Utilisation de nothobranchius furzeri en tant que systeme de modele pour la caracterisation de medicaments qui regulent le vieillissement |
| PCT/IT2006/000238 WO2006106558A2 (fr) | 2005-04-07 | 2006-04-07 | Utilisation de nothobranchius furzeri comme systeme de modele pour la caracterisation des genes du vieillissement |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000169A ITRM20050169A1 (it) | 2005-04-07 | 2005-04-07 | Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITRM20050169A1 true ITRM20050169A1 (it) | 2006-10-08 |
Family
ID=36579492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT000169A ITRM20050169A1 (it) | 2005-04-07 | 2005-04-07 | Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1871427A2 (fr) |
| IT (1) | ITRM20050169A1 (fr) |
| WO (2) | WO2006106544A2 (fr) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH692837A5 (it) * | 1997-07-02 | 2002-11-29 | Lisapharma Spa | Composizione farmaceutica per uso alimentare, dietetico o medicinale adatta a migliorare l'assorbimento orale dei polifenoli e particolarmente del resveratrolo presenti nell'uva e nei suoi p |
| DE69925362T2 (de) * | 1998-02-23 | 2006-01-19 | Phylonix Pharmaceuticals Inc., Cambridge | Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten |
| EP1335645A2 (fr) * | 2000-07-31 | 2003-08-20 | Regents Of The University Of Minnesota | Inhibition de l'expression genique au moyen d'analogues de polynucleotides |
| US20020039725A1 (en) * | 2000-08-17 | 2002-04-04 | Shedd Tommy R. | Fish hatching method and apparatus |
| US6943025B2 (en) * | 2001-01-10 | 2005-09-13 | Children's Medical Center Corporation | Method for identifying genes involved in cell proliferation |
| US20020174447A1 (en) * | 2001-01-23 | 2002-11-21 | Greenspan Ralph J. | Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease |
| WO2003052106A1 (fr) * | 2001-12-17 | 2003-06-26 | Children's Medical Center Corporation | Procede de criblage de composes |
| CA2500967A1 (fr) * | 2002-09-11 | 2004-03-25 | Dana-Farber Cancer Institute | Modelisation du cancer a l'aide de poissons transgeniques |
| GB0301977D0 (en) * | 2003-01-28 | 2003-02-26 | Daniolabs Ltd | Method for creating a model amenable to high-throughput screening |
| AU2003901269A0 (en) * | 2003-03-19 | 2003-04-03 | Victor Chang Cardiac Research Institute Limited | Model for muscular dystrophy |
| NZ549354A (en) * | 2004-02-03 | 2009-10-30 | Hybrid Biosciences Pty Ltd | Method of identifying genes which promote hybrid vigour and hybrid debility and uses thereof |
| WO2005098428A2 (fr) * | 2004-04-07 | 2005-10-20 | Marinus Pharmaceuticals, Inc. | Procede et systeme de criblage de composes pour leur activite musculaire et/ou neurologique chez des animaux |
| GB2413847A (en) * | 2004-04-26 | 2005-11-09 | Daniolabs Ltd | Bone disease models |
-
2005
- 2005-04-07 IT IT000169A patent/ITRM20050169A1/it unknown
- 2005-12-22 WO PCT/IT2005/000753 patent/WO2006106544A2/fr not_active Ceased
- 2005-12-22 EP EP05823575A patent/EP1871427A2/fr not_active Withdrawn
-
2006
- 2006-04-07 WO PCT/IT2006/000238 patent/WO2006106558A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006106544A3 (fr) | 2007-05-18 |
| WO2006106558A3 (fr) | 2007-03-15 |
| EP1871427A2 (fr) | 2008-01-02 |
| WO2006106558A2 (fr) | 2006-10-12 |
| WO2006106544A2 (fr) | 2006-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITRM20040362A1 (it) | Sistema per la realizzazione di costruzioni complesse. | |
| EP2037737A4 (fr) | Protéines, acides nucléiques encodant celles-ci et leurs procédés d'utilisation associés | |
| DE602004016054D1 (de) | Brennstoffzellensystem | |
| EP1824971A4 (fr) | Genes clostridiaux genetiquement modifies, proteines codees par ces genes modifies et utilisations de ceux-ci | |
| DE502004011730D1 (de) | Brennstoffzellensystem | |
| DE602005027567D1 (de) | 1-aza-bicycloä3.3.1ünonane | |
| ITMO20030134A1 (it) | Sistema di pesatura | |
| DE602004004068D1 (de) | Speichersteuerungssystem | |
| FI20041642A0 (fi) | Jarrukatkoja | |
| EP1908480A4 (fr) | Regulateur d'interferon- alpha | |
| FI20045252L (fi) | AV-järjestelmä sekä ohjain | |
| ITRM20050169A1 (it) | Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento. | |
| DE112004002487D2 (de) | Brennstoffzellensystem | |
| ITRM20030283A0 (it) | Mezzi terapeutici e diagnostici per i papillomi. | |
| ITMI20031075A1 (it) | Sistema per il comando di sblocco negli schienali | |
| ITVE20040039A1 (it) | Complesso di elementi modulari per la realizzazione di mobili componibili. | |
| ITMI20021774A1 (it) | Sistema per realizzare materassi personalizzati. | |
| ITRM20030440A0 (it) | Sistema d'indicazione temporale, in particolare dell'orario. | |
| ITMC20030116A1 (it) | "sistema di corde salvavita" | |
| ITRM20040003A1 (it) | Sistema modulare, in particolare per la realizzazione di strutture espositive. | |
| FI20040257A0 (fi) | Parannus puoliperävaunujärjestelmässä | |
| FR2881050B1 (fr) | Dcchol chez les nouveaux-nes | |
| FI20030825A0 (fi) | Parvijärjestelmä | |
| ITMI20051624A1 (it) | Sistema di controllo dell'erogazione di carburanti | |
| ITPD20040024A1 (it) | Sistema di connessione rapida, particolarmente per la connessione di elementi di strutture espositive |